COVID-19 Academic Resources Center
 

MDPI Comment on the COVID-19 Virus

Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.

The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.

This page contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.

Recent Publications

27 pages, 1367 KiB  
Review
Molecular Hydrogen in the Treatment of Respiratory Diseases
by Dominika Zajac, Monika Jampolska and Piotr Wojciechowski
Int. J. Mol. Sci. 2025, 26(9), 4116; https://doi.org/10.3390/ijms26094116 (registering DOI) - 26 Apr 2025
Abstract
Molecular hydrogen is gaining increasing attention as an antioxidant, anti-inflammatory, and antiapoptotic agent. Once considered an inert gas, it reveals current therapeutic potential among others in inflammatory diseases, cancer, and sports medicine, among others. The present review aims to provide a consistent summary [...] Read more.
Molecular hydrogen is gaining increasing attention as an antioxidant, anti-inflammatory, and antiapoptotic agent. Once considered an inert gas, it reveals current therapeutic potential among others in inflammatory diseases, cancer, and sports medicine, among others. The present review aims to provide a consistent summary of the findings of the last twenty years on the use of molecular hydrogen in major respiratory diseases, including allergies, asthma, COPD, pulmonary fibrosis, lung injury of various origins, as well as cancer and infections of the respiratory tract. In addition, the basic mechanisms through which molecular hydrogen exercises its biological activity on the respiratory system are described. Full article
(This article belongs to the Special Issue Physiology and Molecular Medicine of Molecular Hydrogen)
Show Figures

Figure 1

28 pages, 2425 KiB  
Review
Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations
by Muhammad Awais Ashraf, Bei Shen, Muhammad Asif Raza, Zhu Yang, Muhammad Nabeel Amjad, Ghayyas ud Din, Lihuan Yue, Afifa Kousar, Qudsia Kanwal and Yihong Hu
Curr. Issues Mol. Biol. 2025, 47(5), 303; https://doi.org/10.3390/cimb47050303 (registering DOI) - 26 Apr 2025
Abstract
Albumin is the most abundant plasma protein, accounting for approximately 50% of total serum protein in healthy individuals. In recent years, albumin has attracted significant attention due to its biocompatibility, non-toxicity (metabolizing in vivo into harmless degradation products), non-immunogenic properties, ease of purification, [...] Read more.
Albumin is the most abundant plasma protein, accounting for approximately 50% of total serum protein in healthy individuals. In recent years, albumin has attracted significant attention due to its biocompatibility, non-toxicity (metabolizing in vivo into harmless degradation products), non-immunogenic properties, ease of purification, and water solubility. These characteristics render it an ideal candidate for a wide range of biomedical applications. Its uses include drug delivery systems, wound healing, antioxidant therapies, infusion treatments, COVID-19 therapeutics, tissue engineering, and other critical care domains. Consequently, the global demand for albumin has been steadily increasing. The international albumin market was valued at USD 5394.9 million in 2021 and is projected to reach USD 9192 million by 2030, with a compound annual growth rate (CAGR) of 6.1%. Given its diverse applications and rising demand, substantial efforts have been made to ensure a sustainable supply of albumin. This review provides an overview of albumin, along with its novel applications, purification methods, and market trends. Full article
(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
Show Figures

Figure 1

13 pages, 338 KiB  
Article
Analysis of the Use of Over-the-Counter Therapy for the Prevention and Treatment of COVID-19
by Ivan Vukosavljević, Nataša Djorić, Ivana Vukosavljević, Jasmina Milovanović, Nataša Zdravković, Katarina Djordjević, Nebojša Zdravković, Marina Kostić, Ana Barjaktarević, Snezana Cupara, Ivan Čekerevac, Nevena Vasović, Aleksandra Tomić Lučić, Marija Šorak, Nikola Mirković and Olivera Kostić
Medicina 2025, 61(5), 803; https://doi.org/10.3390/medicina61050803 (registering DOI) - 25 Apr 2025
Abstract
Background and Objectives: Self-medication includes the use of drugs or herbal preparations based on one’s own discretion or the recommendation of another person, often a family member, friend, neighbor, or even a pharmacist, without prior examination and consultation with a doctor. The [...] Read more.
Background and Objectives: Self-medication includes the use of drugs or herbal preparations based on one’s own discretion or the recommendation of another person, often a family member, friend, neighbor, or even a pharmacist, without prior examination and consultation with a doctor. The goal of this study was to determine respondents’ reasons for using self-medication, determine the frequency of self-medication, and analyze differences in respondents’ attitudes about self-medication in relation to several factors. Materials and Methods: The study was conducted as a cross-sectional observational study. The respondents were patients seeking medical examination at the Health Center in Jagodina who had used over-the-counter medications during the COVID-19 pandemic. A total of 175 respondents participated in the study. The study design provided answers to questions about the respondents’ self-medication habits during the COVID-19 pandemic. Results: More than half of the respondents (53.71%) bought medicines without a prescription, with most cases involving analgesics (52.83%). Almost three-quarters of the respondents were completely vaccinated (74.29%) against COVID-19. Additionally, 39.62% of participants used vitamins as part of their self-medication during the COVID-19 pandemic. Among the vitamins, respondents most commonly used a combination of vitamins C and D (20.75%), vitamin D (5.66%), vitamin C (5.66%), and vitamin A (1.89%). Conclusions: Self-medication for the treatment of coronavirus is more often used by younger respondents, who are not yet married, do not have their own income, and rarely visit a doctor. As for supplements, respondents used zinc, and as for vitamins, respondents mostly used a combination of vitamins C and D. Full article
(This article belongs to the Section Epidemiology & Public Health)
20 pages, 548 KiB  
Article
Parents as Allies: Innovative Strategies for (Re)imagining Family, School, and Community Partnerships
by Emily Markovich Morris and Yu-Ling Cheng
Educ. Sci. 2025, 15(5), 533; https://doi.org/10.3390/educsci15050533 - 25 Apr 2025
Abstract
Research conducted during the COVID-19 pandemic in rural, urban, and suburban public schools in southwestern Pennsylvania indicated that families and school educators and leaders had different views on education and that more needed to be done to build family, school, and community partnerships. [...] Read more.
Research conducted during the COVID-19 pandemic in rural, urban, and suburban public schools in southwestern Pennsylvania indicated that families and school educators and leaders had different views on education and that more needed to be done to build family, school, and community partnerships. The Parents as Allies Partnership, a collective of community, education, and research institutions, emerged out of this study and has led the co-creation of a human-centered design process with school teams on how to radically reimagine and support family, school, and community collaboration in southwestern Pennsylvania. Through the human-centered design process, teams of families, teachers, staff, and school leaders develop innovative solutions together to address pressing needs they identify in their communities. This article details this community-building process alongside case studies of three schools and how they have used the research to launch deeper and more inclusive and equitable familycentric partnership practices. This study challenges educators, researchers, and parent organizations to think differently about family, school, and community engagement and provides an evidence-based process to apply in their own contexts. Full article
14 pages, 272 KiB  
Article
Evaluating Predictive Value of Plasma Free Hemoglobin (PFH) in ECMO for COVID-19, Non-COVID-19 Pulmonary, and Cardiac Patients
by Wasiq Rashid, Varshith Paduchuri, Joby Chandy, John Hodgson and Enrico Camporesi
Medicina 2025, 61(5), 801; https://doi.org/10.3390/medicina61050801 - 25 Apr 2025
Abstract
Background and Objectives: Extracorporeal membrane oxygenation (ECMO) can support patients with severe cardiopulmonary failure, but it poses risks such as hemolysis, leading to complications. Plasma-free hemoglobin (PFH) is a hemolysis biomarker, with elevated levels linked to mortality. This study evaluates PFH and [...] Read more.
Background and Objectives: Extracorporeal membrane oxygenation (ECMO) can support patients with severe cardiopulmonary failure, but it poses risks such as hemolysis, leading to complications. Plasma-free hemoglobin (PFH) is a hemolysis biomarker, with elevated levels linked to mortality. This study evaluates PFH and ECMO survival in COVID-19, non-COVID-19 pulmonary, and cardiac patients, focusing on late PFH spikes. Materials and Methods: We retrospectively analyzed 122 ECMO patients treated at our tertiary hospital (January 2020–December 2021). Patients were categorized by indication: post-COVID-19, non-COVID-19 pulmonary, or cardiac. We classified patients as Expired (died during ECMO or ≤30 days post-ECMO) or Survived (>30 days post-ECMO). Data included demographics, ECMO duration, and PFH values at 24 h and during the last 3 and 5 ECMO days. Groups were compared using two-tailed t-tests, with p < 0.05 indicating significance. Results: COVID-19 patients survived after significantly longer ECMO duration than non-COVID-19 pulmonary and cardiac patients. Expired COVID-19 patients had higher PFH values during the last 3 and 5 days of ECMO compared to survivors. Cardiac patients had the highest overall PFH levels regardless of mortality. No significant differences in PFH trends were observed between non-COVID-19 pulmonary and cardiac patients. Conclusions: Late PFH spikes correlated with mortality in COVID-19 patients, suggesting the utility of measuring late PFH spikes in ECMO management. Additionally, COVID-19 pulmonary patients survived when undergoing ECMO significantly longer than both groups, while VA ECMO was more prone to hemolysis. However, technical cannulation differences and frequent use of an Impella pump in cardiac patients may increase blood stress and PFH values. Full article
(This article belongs to the Section Intensive Care/ Anesthesiology)
35 pages, 5011 KiB  
Review
A Disintegrin and Metalloprotease with Thrombospondin Motif, Member 13, and Von Willebrand Factor in Relation to the Duality of Preeclampsia and HIV Infection
by Prelene Naidoo and Thajasvarie Naicker
Int. J. Mol. Sci. 2025, 26(9), 4103; https://doi.org/10.3390/ijms26094103 - 25 Apr 2025
Abstract
Normal pregnancy is associated with multiple changes in the coagulation and the fibrinolytic system. In contrast to a non-pregnant state, pregnancy is a hypercoagulable state where the level of VWF increases by 200–375%, affecting coagulation activity. Moreover, in this hypercoagulable state of pregnancy, [...] Read more.
Normal pregnancy is associated with multiple changes in the coagulation and the fibrinolytic system. In contrast to a non-pregnant state, pregnancy is a hypercoagulable state where the level of VWF increases by 200–375%, affecting coagulation activity. Moreover, in this hypercoagulable state of pregnancy, preeclampsia is exacerbated. ADAMTS13 cleaves the bond between Tyr1605 and Met1606 in the A2 domain of VWF, thereby reducing its molecular weight. A deficiency of ADAMTS13 originates from mutations in gene or autoantibodies formed against the protease, leading to defective enzyme production. Von Willebrand protein is critical for hemostasis and thrombosis, promoting thrombus formation by mediating the adhesion of platelets and aggregation at high shear stress conditions within the vessel wall. Mutations in VWF disrupts multimer assembly, secretion and/or catabolism, thereby influencing bleeding. VWF is the primary regulator of plasma ADAMTS13 levels since even minute amounts of active ADAMTS13 protease have a significant inhibitory effect on inflammation and thrombosis. VWF is released as a result of endothelial activation brought on by HIV infection. The SARS-CoV-2 infection promotes circulating proinflammatory cytokines, increasing endothelial secretion of ultra large VWF that causes an imbalance in VWF/ADAMTS13. Raised VWF levels corresponds with greater platelet adhesiveness, promoting a thrombotic tendency in stenotic vessels, leading to increased shear stress conditions. Full article
(This article belongs to the Special Issue Pathogenesis of Preeclampsia: From a Molecular Perspective)
Show Figures

Figure 1

Sequencing Techniques and Genomics Technologies to Help with Diagnostics and Virus Characterization – Focus on COVID 19
edited by , Hugh E. Olsen, and
submission deadline 15 Apr 2021 | 10 articles | Viewed by 65042
Keywords: Genomics technologies; Sequencing techniques; Metagenomics; Virus sequencing; Genetic diagnostics; qPCR; Nanopore sequencing; Single-molecule real-time (SMRT) sequencing; Next-generation sequencing (NGS); Third-generation sequencing; Virus characterization; Long-read sequencing; Comparative genomics; Functional genomics; Diagnostic tests; Infectious diseases; Pandemic; SARS-CoV-2; COVID-19; Coronavirus; Genomic epidemiology; Population stratification; Genetic susceptibility; Host interactions
(This special issue belongs to the Section Technologies and Resources for Genetics)
COVID-19 and Pneumonia, 3rd Edition submission deadline 30 Apr 2025 | 6 articles | Viewed by 6695 | Submission Open
Keywords: COVID-19; pneumonia; lung diseases; diagnosis; treatment; prognosis
(This special issue belongs to the Section Coronaviruses)
The End of the COVID-19 Pandemic—What Is Currently Known and What Could Have Been Useful Four Years Ago? (2nd Edition) submission deadline 30 Apr 2025 | 12 articles | Viewed by 20980 | Submission Open
Keywords: COVID-19; SARS-CoV-2; pandemic; diagnosis; biomarkers; treatment; immunity; inflammation; cytokines; vaccine
(This special issue belongs to the Section Molecular and Translational Medicine)
Advanced Biomedical Research on COVID-19 (2nd Edition)
edited by
submission deadline 30 Apr 2025 | 4 articles | Viewed by 5165 | Submission Open
Keywords: SARS-CoV-2; COVID-19; antibody; infection; immunity
(This special issue belongs to the Section Immunology and Immunotherapy)
EBV and Disease: New Perspectives in the Post COVID-19 Era
edited by and Dengke Li
submission deadline 30 Apr 2025 | 3 articles | Viewed by 1983 | Submission Open
Keywords: EBV; reactivation and immune dysregulation; EBV-associated malignancies; autoimmune diseases; diagnostic and therapeutic
(This special issue belongs to the Section Human Virology and Viral Diseases)
Physical Fitness and Exercise during and after the COVID-19 Pandemic
edited by
submission deadline 1 May 2025 | 7 articles | Viewed by 12664 | Submission Open
(This special issue belongs to the Section Exercise and Health-Related Quality of Life)

State-of-the-Art Webinars on COVID-19


WEBINAR 1: How to Avoid a New Lockdown?

The first webinar in the series, held on 17 April 2020, saw both Prof. Dr. Antoine Flahault, Director of the Institute of Global Health, University of Geneva, Switzerland, and Prof. Dr. Evelyne Bischof, Associate Professor, Shanghai University of Medicine and Health Sciences, Shanghai, China and Research physician, University Hospital of Basel, Basel, Switzerland speak on this topic.

The recording can be found here.

WEBINAR 2: Coronaviruses: History, Replication, Innate Immune Antagonism

The second webinar in the series, entitled “Coronaviruses: history, replication, innate immune antagonism”, saw Prof. Dr. Susan R. Weiss, Professor of Microbiology, Perelman School of Medicine, University of Pennsylvania speak on this topic.

The recording can be found here.

WEBINAR 3: Could the COVID-19 Crisis be the Opportunity to Make Cities Carbon Neutral, Liveable and Healthy

The third webinar in this series was presented by Prof. Dr. Mark Nieuwenhuijsen, a world leading expert in environmental exposure assessment, epidemiology, and health risk/impact assessment with a strong focus and interest on healthy urban living. 

The recording can be found here

WEBINAR 4: COVID-19 - Global Supply Chains and the SDGs

For the fourth webinar of this series, Prof. Dr. Max Bergman, Dr. Dorothea Schostok and Prof. Dr. Patrick Paul Walsh gave a presentation on Global Supply Chains and the SDGs. 

The recording can be found here.

WEBINAR 5: The New Role of Family Physicians in Times of COVID-19

The fifth webinar of the COVID-19 Series saw Prof. Dr. Christos Lionis discuss the new role of family physicians that emerged during the COVID-19 pandemic.

The recording can be found here.

WEBINAR 6: Survey on Symptoms/Signs, Protective Measures, Level of Awareness and Perception Regarding COVID-19 Outbreak among Dentists

In the sixth webinar of this series, Prof. Dr. Guglielmo Campus and Prof. Dr. Maria Grazia present and discuss the risk and the preventions that can and should be taken by dentists during this pandemic.

The recording can be found here.

WEBINAR 7: Living with COVID-19: An Early Intervention Therapeutic Strategy to Control the Pandemic

The seventh webinar of the COVID-19 series, Dr. Hamid Merchant discussed the different therapeutic strategies that can be adopted in the early stages of the infection.

The recording can be found here.

WEBINAR 8: Impact of COVID-19 on Routine Immunization, Reproduction and Pregnancy Outcome

For the eighth COVID-19 webinar, Prof. Dr. Jon Øyvind Odland discussed the effect that COVID-19 seems to have on pregnant women; whereas Prof. Dr. Giovanni Gabutti discussed the role of routine immunization as a way of fighting COVID-19.

The recording can be found here.

Open Platforms for Research Dissemination

Follow Us

Back to TopTop